Back to results
US 6,855,543 B1Granted
Plasmid DNA containing reporter gene DNA and use of the same
AssigneeOno Pharmaceutical Co., Ltd.
InventorsHiroshi Hagiya, Masashi Minami, Hisao Tajima
Life of this patent
Estimating the term…
Abstract
A plasmid DNA comprising a novel reporter gene DNA; a transformant transformed with the above plasmid DNA and a DNA encoding a known effector protein; a therapeutic agent for a cancer or an autoimmune disease, comprising both of the above DNAs as active ingredients; and a method for detecting a ligand of an intracellular receptor, comprising using the above transformant.
Claims4
A composition comprising:
- (a) a plasmid DNA comprising in 5′ to 3′ direction, a GAL4 responsive element a promoter, and a polynucleotide encoding a transmembrane region and an apoptosis-inducing domain of a Fas antigen;
- and
- (b) a plasmid DNA encoding a fusion protein comprising in a 5′ to 3′ direction a GAL4 DNA binding region and a nuclear receptor ligand binding region selected from the group consisting of:
- amino acids 166 to 478 of human PPARγ1 subtype receptor, amino acids 194 to 506 of human PPARγ2 subtype receptor, amino acids 164 to 475 of mouse PPARγ1 subtype receptor, amino acids 194 to 505 of mouse PPARγ2 subtype receptor, amino acids 157 to 468 of human PPARα receptor, amino acids 157 to 468 of rat PPARα receptor, amino acids 129 to 441 of human PPARδ receptor, and amino acids 128 to 440 of mouse PPARδ receptor.
1 more element
Dependencies are inferred from the claim text.